The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59Ā years: A phase I randomized, double-blinded, controlled trial.
Vaccine. 2021 Apr 9:S0264-410X(21)00431-X. doi: 10.1016/j.vaccine.2021.04.006. Online ahead of print.
Vaccine. 2021.
PMID: 33875266